Plastic Fittings and Tubing for Pharmaceutical and Medical Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global plastic fittings and tubing for pharmaceutical and medical market size was valued at USD 7.17 billion in 2023 and is estimated to grow at a CAGR of over 6.1% from 2024 to 2032. The demand of disposable medical devices is a key driver for the global market of plastic fittings and tubing for Pharmaceuticals and Medicine.
Infection control and cross-contamination are making healthcare facilities lean towards single-use medical devices. IV sets, catheters, drug delivery systems do utilize plastic fittings and tubing that can provide feasible, safe and sterile solutions to reduce patient risk. This is also encouraging because of the new investments in hospital infrastructure and expansion of healthcare services around the world, enhancing the demand for cost-effective and high-quality plastic components with proper hygiene precautions.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Plastic Fittings and Tubing for Pharmaceutical and Medical Market size in 2023: | USD 7.17 Billion |
| Forecast Period: | 2024 to 2032 |
| Forecast Period 2023 - 2032 CAGR: | 6.1 |
| 2023 Value Projection: | USD 12.13 Billion |
| Historical Data for: | 2021-2023 |
| No of Pages: | 250 |
| Tables, Charts & Figures: | 315 |
| Segments Covered: | Product Type, Materials, End-Use, Distribution Channels |
| Growth Drivers: |
|
| Pitfalls Challenges: |
|
Also, expansion of biopharmaceuticals is a factor propelling the global demand for plastic fittings and tubing in plastic biopharmaceuticals. Growth in this biopharmaceuticals sector is focusing on complex biologics, vaccines, and personalized medicines drives up the demand for sterile, contamination-free fluid handling systems. Fittings and tubing are vital for keeping non-sterile environments during drug making and transfer. They offer flexibility and high chemical resistance and are usually single-use applications. Furthermore, as the biopharmaceutical production is geared towards meeting heightened global healthcare expectations, there is an increasing need for stringent quality plastic materials, which contributes towards market innovation and expansion.
The rising global concern regarding the need to protect the environment has led to the gradual use of non-traditional materials for manufacturing fittings and tubing within the medical and pharmaceutical plastics market. There is also an increase in health regulations which require the care of safe alternatives to materials that are harmful to both patients and the surroundings. Typical plastic materials like PVC and DEHP are now being scrutinized for their harmful effects on health and the environment.
Safer materials that are more ecologically and biologically friendly are starting to be passed as acceptable by manufacturers. Innovations such as phthalate-free, biodegradable, and recyclable materials are emerging. This trend will help meet the increasing needs for eco-friendly medical devices by healthcare providers and patients as well as further lower the carbon footprint of the industry. This shift in bending the rules of delivery medical devices and tightening the rules on the environment improves the perception of the plastic medical device industry and allows the use of fittings and tubing in medicine.
The medical industry is quite highly regulated, which contributes to the problems faced by suppliers of plastic fittings and tubing for pharmaceutical and medical services. These products are a need in the medical sectors since they need to meet stringent criteria for performance, safety, and effectiveness.
In the United States, QSR rules dictate that the manufacturer's quality systems be only the most stringent. So too in the European Union. These rules state that design, production, assembly, testing, and even labeling of the medical devices are regulated. According to the Advanced Medical Technology Association (AdvaMed), these guidelines are constructed so that quality in the medical devices manufacturing is never compromised. These rules are necessary. Domestic companies must also follow the regulations in order not to lose reputation, market value, and credibility in the long run.
North America: The market for drug-related and medical plastic tubes and their fittings is dominated by the United States, which controls 89% of the North America share, along with single-use medical devices which are set to boost the growth rate to 6.6% every year, changing this sector positively till 2032.
Canada, on the other hand, increased their market by 6.2% in 2023, making them the second most investable market after the US. The increase in biotechnology and research institutes needing ultra-modern medical technologies remains the basic reason for this increase since 1.5-inch ball valves are high-quality plastic fittings and tubing.
Europe: Europe fittings and tubing for pharmaceutical and medical market is set to expect a sustained performance as they tend to accomplish the projected 6.1% due to global competition from the other three tier 1 countries. The United Kingdom, Germany, and France account for 28% share on the global stage in plastic fittings and tubing for skyscrapers.
Germany accounted for a 33% share of the market in 2023. There is a strong focus on the market of eco-friendly plastic materials for medical supplies, with innovations driven by an increase in environmental awareness. Strict guidelines such as the Medical Device Regulation (MDR) and In-vitro Diagnostic Regulation (IVDR) create high barriers for entrance, thereby enabling players to sustain growth of approximately 6.6% for Germany.
Asia Pacific: China held a 37% share of the Asia Pacific market for plastic fittings and tubing targeted towards pharmaceutical and medical purposes in 2023, which positions them at the front of the competition. From 2024 to 2032, this share is expected to grow at a CAGR of 6.3%. Emerging urban regions are propelling a growing healthcare sector complemented with inexpensive manufacturing, which is the main driver for this growth. Increasing government expenditure on health supply attracts both foreign and local manufacturers, which helps solidify China as a key market player.
Parker Hannifin, Freudenberg Medical, Nordson, Trelleborg, Smiths Medical together hold a market share of approximately 10-15% in the Plastic Fittings and Tubing for Pharma and Medical segment. Due to the stiff competition, manufacturers are focusing on improving the performance parameters of elastomeric materials, polymers, and silicone.
They will be developing high-performance materials to enhance their ability to achieve the tough requirements of the pharmaceutical and medical technology industries, which will expand their market growth and ensure long growth. These advanced materials must be biocompatible, durable, and chemical resistant in order for drug delivery, fluid management, and other medical devices to function effectively.
Major players operating in the global plastic fittings and tubing industry are:
Market, By Product Type
Market, By Materials
Market, By End Use
Market, By Distribution Channel
The above information is provided for the following regions and countries:
Key players include AP Extrusion, Atlas Copco, Eldon James, Freudenberg Medical, Navtar, New Age Industries, Nordson, Parker Hannifin, Polymer Solutions, Qosina, Raumedic, Saint-Gobain Performance Plastics, Smiths Medical, Tekni-Plex, and Trelleborg.
The U.S. market for plastic fittings and tubing market for pharmaceutical and medical sectors crossed USD 2.45 billion in 2023 and is estimated to grow at a 6.6% CAGR from 2024 to 2032, supported by its advanced and comprehensive healthcare system.
Hospitals and clinics accounted for around 36% of the market share in 2023 and is expected to grow at a 6.4% CAGR through 2032, led by their extensive use of disposable and single-use medical devices.
The global market for plastic fittings and tubing for pharmaceutical and medical was reached USD 7.17 billion in 2023 and is estimated to grow at a 6.1% CAGR from 2024 to 2032, driven by the increasing demand for disposable medical devices.
The plastic tubing segment generated USD 4.01 billion in 2023 and is anticipated to reach around USD 6.86 billion during 2024 to 2032, owing to its flexibility, durability, and ease of customization.